Agenus, an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines designed to activate immune response to cancers and infections, announced that its annual meeting will begin at 5:00 p.m. ET on June 15, 2021 and will be conducted in a virtual format only.
June 15, 2021
· 1 min read